Delivery Order SPE2DB24D1104-SPE2DB24FYBC6
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, at a ceiling value of $6,399.38. The contract has a firm fixed price pricing type and a final completion date of September 27, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $4,305.05 firm fixed price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has an ultimate completion date of August 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The fixed-price contract has a ceiling value of $4,141.27 and a completion date of February 6, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,295,172 units of the GARDASIL 9 SYRINGE 0.5ML vaccine. The contract has a firm fixed price ceiling value of $6,139.24 and a period of performance through July 31, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded various indefinite delivery contracts (IDCs) by the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical and medical supply distributor, for the supply of GARDASIL 9 syringe 0.5ML. The contract has a ceiling value of $15,593.42 and a period of performance through September 17, 2024. It is a firm-fixed-price contract with no set-aside designation. Amerisourcebergen has multiple Indefinite Delivery Contracts (IDCs) with the DLA...
This is a $27,366.39 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of GARDASIL 9 vaccine syringes. The contract has an ultimate completion date of August 1, 2024 and is not set aside for any special categories of contractors. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies for the provision of a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of GARDASIL 9 vaccine syringes, a pharmaceutical product used to prevent certain types of human papillomavirus (HPV) infections. The contract has a ceiling value of $20,339.98 and is a firm fixed-price contract with an ultimate completion date of September 19, 2024. Amerisourcebergen, a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 syringes, a vaccine product, with a ceiling value of $10,072.48 and a period of performance through January 14, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...